The complex process of spermatogenesis requires the expression and precise coordination of a multitude of genes. Abnormal function of such genes is frequently associated with male infertility. Among these candidates is the human BOULE gene that is a possible fundamental mediator of meiotic transition. In this study, we describe for the first time the existence of three BOULE transcript variants (B1, B2 and B3). We investigated their tissue specificity and mRNA transcript levels in 23 testis biopsies from infertile men. B1, B2 and B3 differed solely in their N-terminal sequences, which are encoded by three alternatively spliced exons 1. In humans, all three isoforms are exclusively expressed in the testes in a relative proportion of 80:220:1 for B1, B2 and B3, respectively. RT-PCR quantification revealed significantly reduced mRNA expression of all three variants in testicular biopsies with meiotic arrest (MA) compared with those with qualitatively complete spermatogenesis. Alteration of the B1/B2 and B1/B3 transcript ratios was correlated with reduced meiotic capacity of spermatocytes to produce round spermatids as assessed by flow cytometry. Furthermore, BOULE mRNA reduction in biopsies with MA paralleled the absence of BOULE protein as analysed by immunohistochemistry. In conclusion, the relative proportions of B1, B2 and B3 may serve as predictive markers for meiotic efficiency and thus the probability of finding haploid cells in the human testis. Among the three isoforms, B2 might have the major role for meiotic completion.
Introduction
During spermatogenesis, a series of mitotic and meiotic cell divisions leads to the production of haploid germ cells, which undergo dramatic morphological changes giving rise to spermatozoa. This highly complex process requires the expression and precise coordination of many genes. Dysfunction of such genetic factors is associated with disturbed spermatogenesis and is suspected to be a frequent cause of male infertility (Vogt, 1997; Krausz et al., 2000; Maurer and Simoni, 2000; Foresta et al., 2001; Kostova and Gromoll, 2001; Quintana-Murci et al., 2001; Choi et al., 2004) . The recent description of several candidate infertility genes was the starting point for thorough investigations aimed at clarifying their role in reproduction. Among these candidates is the DAZ (Deleted in Azoospermia) gene family consisting of two autosomal genes, BOULE and DAZL (DAZ-like) and the Y chromosomal DAZ gene cluster. BOULE has been proposed as the progenitor of the DAZ gene family and is widely distributed, ranging from worms to humans (Haag, 2001; Xu et al., 2001; Tung et al., 2006) . DAZL arose from BOULE in an ancestor of vertebrates, and the Y chromosomal DAZ subsequently originated by duplication of DAZL and transposition to the Y chromosome (Saxena et al., 2000; Xu et al., 2001) .
All DAZ members are RNA-binding proteins specifically expressed in the germline and are essential for germ cell development (reviewed in Reynolds and Cooke, 2005) . In Drosophila, male boule mutants are sterile, and their germ cells are arrested at the spermatocyte stage, demonstrating the requirement of boule for meiosis (Eberhart et al., 1996) . In Caenorhabditis elegans, dazl is only needed for female reproduction. Hermaphrodites deficient in dazl are sterile because of blocked oogenesis (Karashima et al., 2000) . In vertebrates, depletion of Xdazl mRNA in Xenopus oocytes results in tadpoles lacking primordial germ cells (Houston and King, 2000) . Mouse Dazl-null mutants are sterile in both sexes, lacking both spermatozoa and oocytes (Ruggiu et al., 1997) .
The function of the DAZ proteins should be highly conserved, because human BOULE and Xenopus Xdazl transgenes can rescue the spermatogenic defect of Drosophila boule mutants, and human DAZ/ DAZL partially rescues the mouse Dazl-null phenotype (Houston et al., 1998; Slee et al., 1999; Vogel et al., 2002; Xu et al., 2003) .
To date, several infertility-related genes have been investigated in an attempt to identify reliable molecular markers that can predict the presence of haploid cells in the testes of infertile men. Thus, the expression levels of human BOULE and CDC25A mRNAs have been shown to be positively correlated with the success of sperm retrieval during testicular sperm extraction (TESE) for assisted reproduction (Lin et al., 2005; Cheng et al., 2006) . In addition, BOULE protein was found in the cytoplasm of primary spermatocytes, and its lack was associated with spermatogenic arrest at the meiotic stage in a large group of patients, independent of the factors causing infertility (Xu et al., 2001; Luetjens et al., 2004) . Owing to its essential role for meiotic transition and thus for haploid germ cell production, BOULE may be considered as a candidate molecular marker for the prediction of complete spermatogenesis.
In this study, we describe for the first time the existence of three BOULE isoforms and investigate their mRNA levels in testicular biopsies of patients with qualitatively complete spermatogenesis or with meiotic arrest (MA). We further analyse meiotic efficiency in relation to the relative proportion of each transcript variant and speculate about the physiological importance of the three isoforms.
Materials and methods

Patients and testicular samples
Twenty-three testis biopsies (21 unilateral and 2 bilateral) from 22 patients attending the Institute of Reproductive Medicine (IRM) in Münster were investigated in this study. The patients were either azoospermic (n = 13) or severely oligozoospermic (<0.1 × 10 6 /ml) (n = 9). All testicular biopsies were obtained in an attempt to retrieve sperm for IVF. All patients underwent a complete clinical and physical examination and gave informed written consent to the procedures and to further studies with their redundant testicular tissue material. The clinical studies were approved by the Ethics Committee of the University and the State Medical Board (Muenster, Germany; no. 4INie1) .
Hormone values were measured in peripheral blood. FSH, LH and prolactin were analysed by immunofluorometric assays (Autodelfia, Wallac, Freiburg, Germany). Serum testosterone was measured using commercial radioimmunoassay kits (DRG Instruments GmbH, Marburg, Germany).
The testicular biopsies analysed in this study were subdivided by histological evaluation into three groups: those with complete spermatogenesis (quantitatively normal or reduced to various degrees, n = 15), where the seminiferous tubules contained elongated spermatids; those with MA (n = 4), defined as biopsies in which primary spermatocytes represented the most advanced spermatogenic stage and those with Sertoli cell only (SCO, n = 4), where seminiferous tubules were completely devoid of germ cells. All biopsies were denoted by patient number, biopsy site (left, L; right, R) and histological diagnosis in the case of MA and SCO.
RNA extraction, RT and quantitative PCR
Commercially derived testis total RNA (BioChain, Hayward, CA, USA) from two healthy men was used as control to analyse the normal distribution of BOULE isoforms. Total RNA from various macaque tissues (testis, epididymis, prostate, liver, kidney, breast, heart and brain) and from human testis biopsies (frozen tissue) was isolated using the Ultraspec® reagent (AMS GmbH, Wiesbaden, Germany), following the manufacturer's protocol.
To remove DNA traces in the RNA preparation, samples were treated with DNase. One microgram of RNA (per 20 μl RT reaction) of each tissue sample was reverse-transcribed using the Superscript II system (Stratagene, Heidelberg, Germany). The efficiency of cDNA synthesis was verified by PCR amplification of the b-actin gene.
Tissue-specific expression of BOULE isoforms 1, 2 and 3 was investigated by PCR amplification using cDNA from human and macaque testes and various macaque control tissues. The forward primers were specific for exon 1A, 1B or 1C, and the reverse primer was located in exon 2, which is common for the three transcript variants. The primer sequences and amplicon sizes were BOULE 1 (247 bp), fw 5′-ACAAGCAGCGCTGCTGCCTTG-3′; BOULE 2 (367 bp), fw 5′-GTTGAGGCTTCCCGCCACTG-3′; BOULE 3 (518 bp for human and 290 bp for macaque), fw 5′-CCAGTGAGGGCACATTGCTTTG-3′; rev 5′-TCAATTCCTCCTACAAAGATGC-3′.
Quantitative PCR analysis of BOULE 1, 2 and 3 was performed by TaqMan methodology using ABI Prism 7000 Sequence Detection System (Applied Biosystems, Darmstadt, Germany), according to the manufacturer's guidelines. Three real-time PCR assays were designed to amplify sequence stretches on the boundary of exons 1 and 2 of each isoform. The primer pairs and FAMlabelled (6-carboxy-fluorescein) probes for each assay were BOULE 1 (amplicon size, 106 bp), fw 5′-AGGTGGTTTCAAACTTTAGGCTTCT-3′, rev 5′-GTTT GCATCTGGTTTGATGTTTGC-3′, FAM probe 5′-CCGGACTCGGTTTCC-3′; BOULE 2 (amplicon size, 145 bp), fw 5′-CAGTGCCGCAACTTGCT-3′, rev 5′-GGCACTTGTTGGGTTATTCAAAGG-3′, FAM probe 5′-TTTGCGTCG-CAGTCACT-3′; BOULE 3 (amplicon size, 104 bp), fw 5′-ATCACGAGGT-CAGGAGATCGA-3′, rev 5′-GCACAGGTGACACAGGATTAGG-3′, FAM probe 5′-CCAAAATGCAAACATCAAAC-3′. All BOULE assays had equal efficiencies (characterized by the slope of the standard curves) allowing comparison of the mRNA levels of the three different transcripts. The 18S gene (commercial assay, Applied Biosystems) was used as endogenous control to normalize for variations in cDNA amounts. Each PCR contained cDNA derived from 100 ng (BOULE assays) or 166 pg (18S assay) total RNA. PCR conditions were 10 min 95°C, 40 × 15 s 92°C and 1 min 60°C (annealing and extension). Samples were analysed in triplicate. Relative gene-expression analysis was performed according to the 2 −ΔΔCt method (Livak and Schmittgen, 2001 ). Decreases in the transcript amounts of BOULE 1, 2 and 3 in the MA and SCO groups were calculated relative to the values obtained from the biopsies with complete spermatogenesis.
Flow cytometry
The cell types in the testicular biopsies (HC, elongated spermatids; 1C, round spermatids; 2C, diploid germ and somatic cells and 4C, tetraploid cells, spermatocytes and dividing 2C cells) investigated in this study were analysed by flow cytometry. The cell ploidy is reflected by the DNA content, which was measured after propidium iodide (PI) staining. Testicular tissue specimens (5-20 mg) from the biopsies were minced in 0.5 ml PI staining solution [0.1 mg/ ml RNase, 0.1% Triton X-100, 25 μg/ml PI in phosphate-buffered saline (PBS) with 1 mg/ml bovine serum albumin (BSA)]. To release cells from the germinal epithelium, samples were mixed several times by aspiration using an electronic dispenser (EDOS 5222, Eppendorf, Hamburg, Germany). After centrifugation (1 min at 40 × g), the supernatant was transferred to a new tube. To release HC cells, the tissue pellet was resuspended in new 0.5 ml PI staining solution and homogenized twice for 3 s at 5000 r.p.m. with an Ultra-Turrax T8 (IKA GmbH Staufen, Germany). Both fractions were pipetted together, thoroughly mixed and allowed to stain for 30 min in the dark, at room temperature. Two hundred microlitres of each sample was mixed with 50 μl fluorescentlabelled count control beads (Cyto-Cal; Duke Scientific Corporation, California, CA, USA) and analysed in a flow cytometer (Beckman Coulter FC500, Krefeld, Germany) at 488-nm laser excitation. For each sample, ∼10 000 particles were analysed. The HC, 1C, 2C and 4C cell populations for each fraction were identified by the DNA staining intensity after elimination of cell debris using Percoll purified donor's ejaculated spermatozoa (HC standard) to set the lower threshold and subtraction of aggregates using the red fluorescence channel auxiliary and intensity dot plot. The numbers of cells per gram testicular tissue were computed and expressed as percentage for each cell population.
Immunohistochemistry
Bouin-fixed, paraffin-embedded biopsies from all patient testes were routinely sectioned at 4 μm. After deparaffinization and rehydration, sections were blocked with 5% (v/v) goat serum, 0.1% (v/v) BSA in Tris-buffered saline (TBS, pH 7.4) for 30 min. Polyclonal primary antibodies against the peptide ETQEDAQKILQEAEKLNYKDKKLN (common to all three isoforms) were used for detection of human BOULE protein (provided by Prof. R. Reijo, San Francisco, CA, USA). Tissue sections were incubated at 1:300 dilution at room temperature for 1 h. After washing, DAKO LSAB2 System (Dako Diagnostika, Hamburg, Germany) was applied, according to the manufacturer's protocol. Briefly, slides were incubated with biotin-labelled goat anti-rabbit immunoglobulins and then with streptavidin conjugated to horseradish peroxidase, 15 min each, at room temperature followed by incubation with diaminobenzidine (DAB) substrate for 15 min. The sections were counterstained with haematoxylin and mounted with DAKO-Faramount (Dako Diagnostika). BOULE protein staining was analysed microscopically (Axioskop, Zeiss, Oberkochen, Germany) with ×25 or ×40 objectives. Digital images at ×400 magnification were acquired with a CCD camera (Axiocam, Zeiss).
Genetic analysis
Analysis of the genomic organization of BOULE, nucleotide sequence alignments and protein motif searches were performed using e-net databases and software tools: www.ncbi.nlm.nih.gov, www.ncbi.nih.gov/BLAST, www.ebi. ac.uk/clustalw, www.genomatix.de/products/Gene2Promoter and http://motif. genome.jp.
Statistical analysis
The software program SigmaStat 32 was used to analyse the data. Hormone values were analysed by one-way analysis of variance (ANOVA) on Ranks, and multiple pairwise comparison was done with Bonferroni's t-test. The differences in the relative transcript numbers for BOULE 1, 2 and 3 in the three Downloaded from https://academic.oup.com/molehr/article-abstract/13/2/85/1239681 by guest on 05 March 2019 histological groups (complete spermatogenesis, MA and SCO) were analysed for statistical significance by the Kruskal-Wallis test and Dunn's multiple pairwise comparison. The correlation between the mRNA ratio for B1/B2 or B1/B3 and the 1C/4C cell ratio was studied by linear regression. For all tests, a P-value <0.05 was considered statistically significant.
Results
Genomic organization of BOULE
All previous studies dealing with BOULE assumed the existence of a single isoform of this gene. In an attempt to study the expression and function of human BOULE, we screened the GenBank database (NC_000002 and several cDNA entries) to derive the coding sequence of the gene and to analyse its genomic organization. Among the several published cDNA clones (partial and complete sequences) displaying homology to BOULE, we identified three different transcripts. Two of them were described as BOULE isoform 1 and 2 (NM_197970 and NM_033030). A third unnamed cDNA sequence, highly similar to these isoforms, we designated isoform 3 (AK093453). RT-PCR amplification of the coding region of all three variants, followed by sequencing, revealed some nucleotide mismatches for BOULE 3. The sequence identified in our screening was submitted to the GenBank (AM295005). Further analysis showed that BOULE 1, 2 and 3 differed solely in their 5′ ends, specifically in exon 1, which is encoded by distinct genomic sequences. Each 'variable' exon 1 is spliced to a common set of constant downstream exons 2-11. According to their position in the genomic structure of BOULE, we assigned exon 1A to isoform 1, exon 1B to isoform 2 and exon 1C to isoform 3 ( Figure 1A ).
Among them, exon 1A displayed the shortest sequence spanning 232 nucleotides (nt). Exons 1B and 1C consisted of 295nt and 382nt, respectively. To investigate whether exons 1A, 1B and 1C showed any similarity in their sequences, we performed ClustalW analysis. The nucleotide alignment displayed no identity between the three exons.
A GenBank search in other animal models showed a related organization in higher primates (chimpanzee) and mice. Analogous structures with respect to the three first exons could be found at genomic level. Nucleotide alignment of 1A, 1B and 1C to the genomic contig of mouse Boule (NC_000067) showed high similarities corresponding to 64% for 1A, 83% for 1B and 43% for 1C. In chimpanzees, identities reached 99% for all three exons (NW_104290). To verify that these isoforms are expressed, as in humans, we screened the cDNA data bank (EMBL). In mice, all three alternatively spliced variants were transcribed (AK016403, AF272859 and NM_029267). In chimpanzees, a single mRNA sequence, corresponding to BOULE 1, is currently described (XM_516011).
The distinct first exons alter the translational start site and lead to a modification in the N-terminal part of the corresponding proteins. Exons 1A and 1C contribute to the coding sequence of BOULE, whereas 1B is non-coding, and the translational start site for this isoform is located in exon 2 ( Figure 1A ). The alternative start codon in BOULE 1 and 3 has led to the recruitment of additional 12 and 6 amino acids (aa), respectively, without shifting the open reading frame (ORF) ( Figure 1C ). To explore whether the extended N termini of BOULE 1 and 3 may add new features to the protein, we screened the initial aa sequences (exon 1 and partially exon 2) for characteristic elements. No specific motifs were found. Another member of the DAZ gene family, the DAZL gene, closely resembled this genomic structure but has only one first exon. Like BOULE 3, the ORF of DAZL starts in exon 1 and encodes a single aa ( Figure 1B) . However, no sequence similarity between the DAZL exon 1 and BOULE exon 1C could be found, and neither did alignment of the DAZL exon 1 with 10-kb genomic sequence upstream of BOULE exon 2 (including exons 1A and 1B) show a significant match.
BOULE mRNA expression and tissue specificity
Previous data showed that BOULE mRNA expression (without discrimination between the different variants) is restricted to germ cells in humans and mice (Xu et al., 2001) . To determine whether all three isoforms of BOULE are expressed and are germ cell-specific, we isolated total RNA from human testes and several other control tissues from the closely related monkey species Macaca fascicularis. Using RT-PCR analysis, products specific for BOULE 1, 2 and 3 were only obtained from human and macaque testes and, in lower amount, from macaque epididymis (Figure 2 ). The faint expression in the epididymis may be associated with the presence of spermatozoa and a small number of other spermatogenic cells released from the testes. The PCR amplicons with the expected size were sequenced to verify their identity.
Quantification of BOULE 1, 2 and 3 in human testes
RT-PCR analysis showed distinct signal intensities for each BOULE isoform. To estimate their relative proportions in human testes of healthy men, we performed TaqMan-based quantification, which showed most abundant expression for BOULE 2, followed by BOULE 1 and 3. The relative ratio for B1:B2:B3 was 80:220:1.
To estimate whether the expression of one or more isoforms was correlated with spermatogenic efficiency, which would vary among the azoospermic or severe oligozoospermic TESE patients, we analysed the mRNA levels of BOULE 1, 2 and 3 and quantified the populations of various germ cell types in the testicular biopsies with qualitatively complete and disturbed spermatogenesis.
Clinical parameters and histopathological groups
Thirteen of the 22 patients included in this study were azoospermic, and 9 were severely oligozoospermic (<0.1 × 10 6 /ml) as diagnosed by routine semen analysis. Four patients displayed qualitatively complete spermatogenesis in one testicle and mixed atrophy (n = 3) or MA (n = 1) in the other. One patient with MA and another with SCO in one testis displayed mixed atrophy on the contralateral side. Therefore, the testicular biopsies investigated in this study [unilateral from 21 patients and bilateral from 1 patient (no. 13)] were grouped according to histological diagnosis. The groups were as follow: (i) 15 with complete spermatogenesis, (ii) 4 with MA and (iii) 4 with SCO. In the group with complete spermatogenesis, five patients were vasectomized, two had maldescended testes, five had other obstructions and three were classified as idiopathic. Three patients with MA were idiopathic, and one had maldescended testes. Among the SCO patients, one was idiopathic; one had bilateral maldescended testes; one was diagnosed with Klinefelter syndrome and the fourth had Hodgkin disease. In none of the patients were Y chromosomal microdeletions detected. In the first group, spermatozoa were successfully retrieved at TESE from 14 of 15 biopsies but failed in 2 of 4 testes with MA and in all SCO biopsies. Significant differences between the histopathological groups were found for the FSH and LH hormone values (Table I) . Patients with MA and those with SCO diagnosis displayed significantly higher FSH levels compared with the group with qualitatively complete spermatogenesis (P = 0.029 and P < 0.01, respectively). Significantly different LH levels were measured for the SCO group versus the group with complete spermatogenesis (P = 0.014).
Quantification of BOULE isoforms in testicular biopsies of infertile patients
In this investigation, we aimed to analyse BOULE mRNA expression in testes with qualitatively complete spermatogenesis and compare the transcript levels with those measured in blocked meiosis or SCO tubules. We were particularly interested to see whether a single isoform was affected or whether an overall alteration might be observed in spermatogenic failure. The mRNA levels of BOULE 1, 2 and 3 were studied in the group with MA as relative changes in transcript numbers compared with the group with qualitatively complete spermatogenesis. SCO samples were included as negative controls.
All BOULE variants were detected in the biopsies with complete spermatogenesis. The mean ratios between BOULE 1, 2 and 3 were 98:172:1, which deviated only slightly from the values estimated in commercially derived testicular RNA from healthy men (80:220:1). The TaqMan quantification in samples with MA showed a significant 5-fold overall decrease in the transcript levels when compared with complete spermatogenesis (Figure 3 and Appendix). The reduction of BOULE 1, 2 and 3 was 3.5-, 5-and 7.7-fold, respectively, and corresponded to ratio of 209:190:1. One of the four samples (13_L_MA) Figure 2 . RT-PCR analysis of BOULE 1, 2 and 3 mRNA expression. Specific cDNA products were observed from human and macaque testes and macaque epididymis. The amplified sequences span the borders from exon 1 and exon 2. The size of the expected products (marked with arrows) was 247 bp for B1, 367 bp for B2 and 518 bp for B3. The PCR product of B3 generated from macaque testes (arrowhead) displayed different size (290 bp) owing to nucleotide exchanges altering the 3′ splice site of its exon 1, as proven by genomic DNA amplification and sequence analysis (data not shown). M, DNA size ladder. from this group displayed apparently higher mRNA levels, resembling the values from the group with complete spermatogenesis. In SCO biopsies, mRNA expression was hardly detectable, and in one sample it was completely lacking (23_R_SCO). The decrease was 479-, 567-, 430-and 462-fold for total BOULE, B1, B2 and B3, respectively (Figure 3 ).
Flow cytometry
For verification of the histological diagnosis and correlation of the BOULE mRNA values to the testicular cell populations, we used flow cytometric analysis. On the basis of the DNA amount (staining intensity), four different cell fractions were identified: elongated spermatids (HC), round spermatids (1C), diploid cells (2C) (spermatogonia and somatic cells) and meiotic spermatocytes (4C). Few cells of the 4C fraction represented dividing 2C cells. Using tissue material from the same testicular biopsies as for the mRNA quantification, we measured the percentage of HC, 1C, 2C and 4C cells (Figure 4 ). Testes with qualitatively complete spermatogenesis showed the presence of all four cell types, although the percentage of cell numbers fluctuated between samples. The mean distribution for each fraction was 11, 35, 38 and 15% for HC, 1C, 2C and 4C, respectively. Furthermore, one patient from this group (2_R) had strongly reduced haploid cell populations (6% HC and 12% 1C), which correlated with diminished BOULE 1, 2, and 3 mRNA expression. In testes with MA only 2C (∼84%) and 4C (∼16%) cells were identified. In contradiction of the histological diagnosis, one biopsy with MA (13_L_MA) displayed low numbers of 1C (9%) cells and in another (19_L_MA) only a few 4C cells could be found (2%). In SCO patients, 2C cells (∼98%) represented the major cell population and only a few 4C (∼2%) cells were counted.
To examine whether BOULE mRNA was correlated with the cell populations present in the testes, the 1C/4C ratio, representative of the extent of meiosis completion, was investigated in relation to the transcript levels. 1C/4C values were positively associated with the transcript amounts of BOULE 1, 2 and 3 (r = 0.444, P = 0.03) ( Figure 5A ). Thus, reduced transcript levels in patients with MA and SCO were associated with zero 1C/4C values. An obvious deviation from this pattern and the initial histological evaluation was found in two biopsies, namely in 13_L_MA and 2_R. In 13_L_MA, diagnosed with MA, the elevated mRNA amount of BOULE 1, 2 and 3 paralleled the presence of 1C cells (9%). In 2_R, a decreased 1C/4C ratio was associated with strongly diminished transcripts.
Because mRNA amounts of BOULE 1, 2 and 3 were altered differentially, we tested the probability whether a modified B1 : B2 : B3 ratio can reflect the efficiency of haploid cell production. Linear regression analysis showed a high negative correlation of B1/B2 (r = 0.670, P = 0.002) and B1/B3 (r = 0.718, P < 0.001) ratios with the 1C/4C cell numbers, both in the group with complete spermatogenesis and that with MA ( Figure 5B and C). B2/B3 was not correlated significantly with 1C/4C (data not shown).
BOULE protein expression
The association between mRNA quantity and BOULE protein expression was investigated by immunohistochemistry on testicular tissue sections from all patient biopsies. Discrimination between BOULE 1, 2 and 3 was not possible because the antibody used was directed to an epitope common to all isoforms. All biopsies with complete spermatogenesis showed BOULE staining. As previously reported (Luetjens et al., 2004) , BOULE protein was found in germ cells of the first meiotic division, detectable from leptotene to diplotene, with highest expression in pachytene spermatocytes ( Figure 6A ). No staining was found in round and elongating spermatids. The protein was exclusively localized in the cytoplasm. Peritubular cells and blood capillaries frequently showed non-specific staining. Three of the four biopsies with MA contained meiotic spermatocytes that completely lacked BOULE expression ( Figure 6B ). In one biopsy (17_L_MA), no tubules containing meiotic cells could be found, although several tissue sections were analysed. All sections from SCO biopsies showed complete absence of spermatogenic cells and solely non-specific staining in peritubular cells and blood vessels ( Figure 6C ).
Discussion
In this study, we describe for the first time the existence of three BOULE isoforms and show that they are expressed in different amounts during complete spermatogenesis. Furthermore, their mRNA levels are significantly decreased in azoospermic patients with MA and paralleled the lack of BOULE protein. Altered B1/B2 and B1/B3 transcript ratios correlated with reduced spermatogenic efficiency. All previous investigations dealing with BOULE are based on the sequence identified by Xu et al. (2001) , corresponding to B2. In this study, we describe two further transcript variants. Each isoform consists of a variable exon 1 and a constant set of common exons 2-11. The three first exons show no apparent similarity and modify the N-terminal part of the proteins by introduction of alternative start codons in the sequence of B1 and B3. Analysis of their protein sequences did not show any specific motifs in their N termini. However, we cannot exclude the possibility that the aa extensions might moderate the structure and/or function of the proteins.
Recent literature describes several examples of gene families with similar genomic organization. For instance, the α and γ clusters of the neural protocadherin (Pcdh) family display structures with variable first exons, which are spliced to a group of common exons (Wu et al., 2001; Zhang et al., 2004) . A genome-wide search identified many other mammalian genes containing multiple variable first exons, for example, glucuronosyltransferase (UGT1), plectin, nitric oxide synthase (NOS1) and glucocorticoid receptor (GR) (Zhang et al., 2004) . This genomic organization of variable and constant regions seems to be highly prevalent in mammalian genomes and provides a genetic mechanism for cell-and tissue-specific regulation of gene expression, as well as developmentally regulated gene expression. In the case of human BOULE, all three isoforms are specifically expressed in testes. This renders unlikely the probability that they are required for tissuespecific expression, as it was demonstrated for Drosophila boule, where three brain-specific isoforms gained a function in the nervous system (Joiner and Wu, 2004) . Because the spermatogenic process is precisely regulated and involves the interplay of multiple factors, it is possible that the transcription of BOULE variants is either developmentally regulated or stage-specifically controlled. However, the age-related expression was not investigated in this study, and the technique used did not allow discrimination of the different germ cell types. To test this, single cell laser-capture combined with RT-PCR will be useful. Furthermore, it is not clear how the age-or cell-specific expression of BOULE 1, 2 and 3 would be controlled if this was the case. Recent studies on the Pcdh gene family have demonstrated that the transcription of each specific gene variant is controlled by a distinct promoter (Tasic et al., 2002; Wang et al., 2002) . Similarly, our preliminary analysis of the genomic sequence of BOULE, using promoter-finder software tools, suggested the existence of three different promoter regions, each preceding one variable first exon (1A, 1B or 1C). On the basis of these data, we hypothesize that the expression of B1, B2 and B3 may be regulated in a similar way. However, it is also possible that the expression is driven by a single promoter upstream of exon 1A. To check this assumption, thorough promoter analysis is necessary.
In evolutionary terms, the acquisition of variable first exons in the genomic sequence of BOULE should be an ancient event because not only humans and primates but also lower mammals, such as mice, display analogous BOULE organization. Screening of the GenBank data showed the existence of even more complex boule variants in Drosophila (NM_079265, NM_168318, NM_168320, NM_168319), where not only the first exon but also several other exons are alternatively spliced. The existence of multiple BOULE isoforms raises the question which of them might be the progenitor form of the gene. Exon 1B showed highest similarity between humans and mice (83%), rendering isoform 2 as the presumable progenitor.
In this study, we showed that all three variants are exclusively expressed in germ cells and seem to be essential for completion of spermatogenesis. Similar association between BOULE mRNA and spermatogenic failure in azoospermic men was found by Lin et al. (2005) , although they did not discriminate between BOULE 1, 2 and 3. Among the three isoforms, B2 displayed most abundant expression in complete spermatogenesis. In testicular biopsies with MA, all transcripts were significantly lower, but BOULE 2 and 3 were affected more strongly than BOULE 1. Furthermore, the increased B1/B2 and B1/B3 ratios reflected less efficient production of haploid germ cells when the groups with MA and complete spermatogenesis were considered together. It is worth noting that when the latter group, in which spermatogenesis differed quantitatively, was considered alone, a stronger correlation (r = 0.777, P < 0.001) could be obtained between B1/B2 and 1C/4C, reflecting spermatogenic efficiencies. In the SCO group, BOULE mRNA was still detectable, although its expression was greatly reduced and approached the TaqMan detection limit. The presence of transcripts is likely to be associated with low numbers of germ cells, considering that disruption of spermatogenesis is frequently non-homogenous, with focal depletion of germ cells in some tubules and intact spermatogenesis in others (Devroey et al., 1995; Silber, 2000) . Furthermore, the mRNA decrease was correlated with the absence of BOULE protein in arrested spermatocytes. This was consistent with previous findings where lack of BOULE protein expression in azoospermic patients was associated with spermatogenic arrest at the meiotic stage (Luetjens et al., 2004) . Considering these findings together, we suggest the following hypothesis about the physiological relevance of each isoform: B3 might have a minor role in spermatogenesis (in adult men) in view of its many-fold lower expression, compared with B1 and B2; the extra aa length of B1 may be causing some sterical hindrance to the active site of the protein, rendering B1 less effective in function than B2. The resulting higher B1/B2 ratio would lead to less effective overall function of BOULE and result in a blocked meiosis. Thus, B2 may play the most important role, and B1 may have supporting or regulatory function in adult human spermatogenesis. However, this hypothesis is based on the mRNA expression levels and may not necessarily reflect the protein variants in the testis.
Presently, the factors that regulate BOULE expression at the mRNA and protein levels are not known. However, there must be a general molecular mechanism regulating the expression of BOULE and other genes involved in the meiotic cell cycle. Analogous histopathology with lack of BOULE protein and transcript reduction was apparent in the biopsies from the group with MA, although the spermatogenic damage has a different aetiology. This suggests that other meiotic factors upstream of BOULE might control its expression. Studies in Drosophila describe a multitude of genes that are essential for the mitosis-meiosis transition, for example, aly, comr, achi/vis, can, mia, sa and nht (Perezgasga et al., 2004) . The aly gene family is conserved from plants to humans and is essential for the transcriptional activation of several genes, including twine and boule (White-Cooper et al., 2000) . Thus, analogous genes might be involved in the transcription and/or translation of human BOULE.
In this study, some discrepancies between histological diagnosis and flow cytometry data were observed. Thus, in 1 patient with MA, as evaluated by histology, round spermatids were detected by flow cytometry. This could be explained either by a failure to determine the spermatids in the histology or by the presence of different cell types in the tissue pieces used in the two distinct analyses. In another patient with complete spermatogenesis, strongly reduced amounts of haploid cells were detected. In both cases, the cell type estimation by flow cytometry correlated precisely with the mRNA amount of BOULE, confirming the quantitative RT-PCR method as a valuable tool for investigating histopathology in TESE samples. Because the testicular histology may be variable throughout the testis, fine needle aspiration biopsies (FNAB) from multiple tissue locations would provide more precise diagnosis. In addition, recent studies demonstrate that FNAB is less invasive than standard testicular biopsy and, in combination with the RT-PCR technique, is an accurate diagnostic tool (Bettella et al., 2005; Letsas et al., 2006) .
In conclusion, we identified three BOULE transcript variants and have measured a significant decrease in their mRNA levels in biopsies from patients with MA. An altered ratio between the isoforms (B1/B2 and B1/B3) was negatively associated with meiotic efficiency both in qualitatively complete spermatogenesis and MA. Considering this observation and the most abundant mRNA expression of B2, we suggest a major physiological role for this isoform in complete spermatogenesis. Although the observed association needs confirmation by further studies, we propose that BOULE transcript levels and their proportions provide valuable molecular markers for the presence of haploid germ cells in testes of patients with disturbed spermatogenesis. 
